NIH Names Four to NIAID Advisory Council
The National Institutes of Health (NIH) announced the appointment
of four new members to the National Advisory Allergy and Infectious
Diseases Council, the principal advisory body of the National Institute
of Allergy and Infectious Diseases (NIAID). NIAID is part of NIH,
an agency within the Department of Health and Human Services.
The council provides recommendations on the conduct and support
of research, including training young scientists and disseminating
health information derived from NIAID research. It embodies a diverse
perspective on science, health, and the human impact of disease.
The council is composed of physicians, scientists and representatives
of the public who contribute their time and expertise for a four-year
The new council members are: Richard Insel, M.D., executive vice
president of research at the Juvenile Diabetes Research Foundation
International (JDRF), New York; Martin G. Myers, M.D., professor
of pediatrics and preventive medicine and community health at the
University of Texas Medical Branch, Galveston; Shelley M. Payne,
professor of molecular genetics and microbiology at the University
of Texas at Austin; and Gary Schoolnik, M.D., professor of medicine,
microbiology and immunology at the Stanford Medical School.
Dr. Insel leads the strategic direction and oversight for the
$100 million in research grants annually awarded to universities
and researchers by JDRF — the world’s largest charitable
supporter of juvenile diabetes research. He previously served as
a professor of pediatrics, microbiology and immunology at University
of Rochester School of Medicine and Dentistry Medical Center. Dr.
Insel’s research interests include the somatic hypermutation
of immunoglobulin genes, generation of memory B-cells, Haemophilus
influenza vaccines and developmental immunology.
Dr. Myers serves as the Associate Director for Public Health Policy
and Education of the Sealy Center for Vaccine Development at the
University of Texas Medical Branch at Galveston. Dr. Myers also
is the President and Board Chair of a new nonprofit corporation,
Immunizations for Public Health, and is the director and editor
for National Network for Immunization Information. Dr. Myers previously
served as Director of the National Vaccine Program Office at HHS.
Prior to that appointment, he was Director of Pediatric Infectious
Diseases first at the University of Iowa in Iowa City and then
at the Children’s Hospital Medical Center in Cincinnati.
Dr. Payne is a member of the Institute of Cellular and Molecular
Biology, and Distinguished Teaching Professor at the University
of Texas at Austin. Dr. Payne’s research focuses on the molecular
biology of bacterial pathogens including Shigella and Vibrio cholerae,
and she received an NIH MERIT award for studies on Shigella pathogenesis.
She has served as a member and chair of an NIH study section and
is on the editorial board of Infection and Immunity.
Dr. Schoolnik is an attending physician in infectious diseases
at Stanford Medical Center. Dr. Schoolnik’s research employs
molecular genetic and genomic methods and combines laboratory and
field work (in Mexico and Bangladesh) to study infectious agents
that are significant causes of disease in developing countries.
A particular current interest is the molecular ecology of infectious
agents in natural environmental habitats. He served as a co-chair
of the NIAID Blue Ribbon Panel on Bioterrorism Research and was
a founding editor of Molecular Microbiology.
NIAID is a component of the National Institutes of Health, an agency
of the U.S. Department of Health and Human Services. NIAID supports
basic and applied research to prevent, diagnose and treat infectious
diseases such as HIV/AIDS and other sexually transmitted infections,
influenza, tuberculosis, malaria and illness from potential agents
of bioterrorism. NIAID also supports research on transplantation
and immune-related illnesses, including autoimmune disorders, asthma
and allergies. News releases, fact sheets and other NIAID-related materials are
available on the NIAID Web site at http://www.niaid.nih.gov.